Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
NCT06690099 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2025-06-03
Summary
The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.
Conditions
- Rhesus D Genotype
- Pregnancy
Sponsors & Collaborators
-
Devyser Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-07
- Primary Completion
- 2026-06-30
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Collection of Whole Blood Specimens in Pregnant Women
NCT03590678 ·Status: COMPLETED
-
Development of New Prenatal Diagnostic Tests From Maternal Blood
NCT00314691 ·Status: TERMINATED ·Phase: NA
-
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
NCT03620110 ·Status: COMPLETED
-
Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.
NCT02969174 ·Status: APPROVED_FOR_MARKETING
-
A New Prenatal Blood Test for Down Syndrome
NCT00877292 ·Status: COMPLETED
-
Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders
NCT02339402 ·Status: UNKNOWN
-
Pregnancy and Fibrinogen Disorders
NCT03920332 ·Status: COMPLETED
-
Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women
NCT05245734 ·Status: RECRUITING ·Phase: PHASE4
-
Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
NCT01322529 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT02317965 ·Status: UNKNOWN
-
National Prevalence and Impact of Noninvasive Prenatal Testing
NCT02284399 ·Status: COMPLETED
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494 ·Status: COMPLETED
-
Study of Placental Function in Healthy and Pathological Pregnancies
NCT02321007 ·Status: RECRUITING
-
Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers
NCT01009723 ·Status: UNKNOWN
-
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688 ·Status: COMPLETED
-
Prenatal Screening for Down Syndrome With DNAFirst
NCT01966991 ·Status: COMPLETED
-
Vitamin D Deficiency With Selected Vitamin D Receptor Gene Polymorphism in Gestational Hypertension
NCT05659173 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Study on Feto-maternal outcoMe In aNemIc womEn
NCT05739097 ·Status: UNKNOWN
-
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
NCT06575309 ·Status: RECRUITING
-
Improving Women's and Children's Health Via Biobanking and Electronic Registry
NCT03938129 ·Status: COMPLETED
-
Racial Differences: Nitric Oxide(NO) and Endothelin-1(ET-1) in Preeclampsia (PreE)
NCT00653809 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED